Fact Meets Function

Thymosin beta 4: An emerging therapeutic candidate for kidney diseases.

This research review examines TB4-Fragment’s potential for treating kidney disease. The peptide shows promise in protecting kidney cells, reducing inflammation, and preventing harmful scarring in both acute and chronic kidney injuries. While the results are encouraging across multiple studies, researchers note that peptide stability and delivery remain key challenges for practical clinical use.

Thymosin beta 4: An emerging therapeutic candidate for kidney diseases. Read Post »

An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-Inflammatory and antioxidant.

Researchers developed an injectable filler composed of hydroxyapatite microspheres loaded with GHK-Cu tripeptide and evaluated its anti-inflammatory and antioxidant properties in laboratory conditions. The formulation was tested using in vitro cell culture models to assess its biological activity. This is in vitro research, representing early-stage evidence that precedes animal and human clinical testing.

An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-Inflammatory and antioxidant. Read Post »

Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease.

This review article examines host defense peptides (HDPs), particularly KPV, as potential therapeutic agents for inflammatory bowel disease (IBD), discussing their mechanisms of action in modulating immune responses and reducing intestinal inflammation. The authors synthesize evidence from multiple study types—including in vitro, animal models, and human clinical investigations—to evaluate HDPs as a novel drug development strategy for IBD management. The evidence level is review article, which synthesizes findings across human clinical, animal model, and in vitro studies rather than presenting original research data.

Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease. Read Post »

Protective Functions of β-Alanyl-L-Histidine and Glycyl-L-Histidyl-L-Lysine Glycoconjugates and Copper in Concert.

This study shows that GHK-Cu becomes more stable and effective when combined with certain sugar molecules. The enhanced version acts as a copper delivery system that increases copper levels inside cells, which then triggers the production of important growth factors like BDNF for brain health, BMP-2 for bone formation, and VEGF for blood vessel growth. The copper delivery also boosts antioxidant protection by enhancing SOD enzyme activity.

Protective Functions of β-Alanyl-L-Histidine and Glycyl-L-Histidyl-L-Lysine Glycoconjugates and Copper in Concert. Read Post »

Development and evaluation of a novel prehospital antidote service providing methylthioninium chloride (methylene blue) for sodium nitrite poisoning.

This study describes how emergency medical services developed a treatment protocol using methylene blue as an antidote for sodium nitrite poisoning. Sodium nitrite poisoning causes dangerous levels of methemoglobin in the blood, which prevents proper oxygen transport. Methylene blue was used by specialized paramedic teams to reverse this life-threatening condition. This represents a specific emergency medical application rather than a general health supplement use.

Development and evaluation of a novel prehospital antidote service providing methylthioninium chloride (methylene blue) for sodium nitrite poisoning. Read Post »

Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.

This narrative review examined the evidence for BPC-157, a synthetic peptide derived from gastric juice, in promoting musculoskeletal tissue healing across multiple tissue types. The review identified promising preclinical findings in animal models showing potential benefits for tendon, ligament, muscle, and bone healing, though human clinical evidence remains limited and mostly anecdotal. The evidence base is primarily animal model and in vitro studies, with very few human clinical trials available to date.

Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Read Post »

Effect of intraoperative methylene blue on postoperative delirium in elderly patients undergoing joint replacement: a randomized controlled trial.

This randomized controlled trial investigated whether intraoperative methylene blue administration reduces postoperative delirium in elderly patients undergoing joint replacement surgery. The study found that methylene blue treatment was associated with a lower incidence of postoperative delirium compared to control, with specific reductions in both the rate and severity of delirium during the postoperative period. This evidence is from a human clinical trial, representing a higher level of evidence for clinical outcomes.

Effect of intraoperative methylene blue on postoperative delirium in elderly patients undergoing joint replacement: a randomized controlled trial. Read Post »

Protective effect of nicotinamide mononucleotide against soybean isoflavone induced damage in mouse testis.

This animal model study investigated whether nicotinamide mononucleotide (NMN) could protect mouse testis tissue from damage induced by soybean isoflavones, examining potential mechanisms of cellular protection. The researchers found that NMN treatment provided protective effects against the testicular damage caused by isoflavone exposure in mice. This evidence is derived from an animal model study and therefore has limited direct applicability to human populations.

Protective effect of nicotinamide mononucleotide against soybean isoflavone induced damage in mouse testis. Read Post »

Challenge of Corneal Ulcer Healing: A Novel Conceptual Framework, the “Triad” of Corneal Ulcer Healing/Corneal Neovascularization/Intraocular Pressure, and Avascular Tendon Healing, for Evaluation of Corneal Ulcer Therapy, Therapy of Neovascularization, Glaucoma Therapy, and Pentadecapeptide BPC 157 Efficacy.

This animal model study examined corneal ulcer healing mechanisms by proposing an integrated conceptual framework linking corneal ulcer healing, corneal neovascularization, and intraocular pressure changes, with comparison to avascular tendon healing processes. The research evaluated the pentadecapeptide BPC 157 as a potential therapeutic agent across these interconnected corneal pathology domains. The study presents a theoretical model for understanding corneal wound healing complications and proposes criteria for evaluating therapeutic interventions in corneal disease, though findings are based on animal model evidence.

Challenge of Corneal Ulcer Healing: A Novel Conceptual Framework, the “Triad” of Corneal Ulcer Healing/Corneal Neovascularization/Intraocular Pressure, and Avascular Tendon Healing, for Evaluation of Corneal Ulcer Therapy, Therapy of Neovascularization, Glaucoma Therapy, and Pentadecapeptide BPC 157 Efficacy. Read Post »

Association between blood nicotinamide adenine dinucleotide levels and blood laboratory parameters at baseline and after nicotinamide mononucleotide supplementation in middle-aged healthy individuals: post hoc analysis of a randomized, double-blinded, placebo-controlled clinical trial.

This post hoc analysis of a randomized, double-blinded, placebo-controlled human clinical trial examined the relationship between blood NAD+ levels and various laboratory parameters in middle-aged healthy individuals, both at baseline and following nicotinamide mononucleotide (NMN) supplementation. The study identified associations between NAD+ levels and specific blood biomarkers, with changes occurring after NMN supplementation in this population. **Evidence level: Human clinical trial**

Association between blood nicotinamide adenine dinucleotide levels and blood laboratory parameters at baseline and after nicotinamide mononucleotide supplementation in middle-aged healthy individuals: post hoc analysis of a randomized, double-blinded, placebo-controlled clinical trial. Read Post »

Scroll to Top